-
NATIONWIDE PATHOLOGY SERVICES NETWORK STUDY ON DISINVESTMENT AND INVESTMENT STRATEGIES: A STUDY PROTOCOL
Feb 25, 2026, 14:41 PM -
EVOLUTION OF PATIENT-REPORTED BURDEN AND UNMET NEEDS IN HEREDITARY ANGIOEDEMA: A COMPARATIVE SOCIAL MEDIA LISTENING ANALYSIS
Feb 25, 2026, 14:41 PM -
CHARACTERIZING AGE-RELATED PATTERNS IN HEALTHCARE COSTS AND UTILIZATION AMONG PEOPLE LIVING WITH ANGELMAN SYNDROME IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
HEALTH RELATED QUALITY OF LIFE IN ULCERATIVE COLITIS: A SYSTEMATIC EVALUATION OF INSTRUMENTS AND THEIR PSYCHOMETRIC VALIDATION
Feb 25, 2026, 14:41 PM -
UTILIZATION OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) FOR WEIGHT LOSS AND DIABETES: A STATE-LEVEL ANALYSIS ACROSS PAYER TYPES
Feb 25, 2026, 14:41 PM -
USER EVALUATION OF AN AGENTIC AI ASSISTANT FOR REAL-WORLD EVIDENCE FEASIBILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
FORECASTING THE DIALYSIS BURDEN IN MOROCCO AND THE ECONOMIC VALUE OF EARLY NEPHROPROTECTION : A 2025-2035 MARKOV-BASED MULTISCENARIO PROJECTION (PROMOD STUDY)
Feb 25, 2026, 14:41 PM -
BURDEN OF HYPERTENSION AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS IN INDIA: EVIDENCE FROM A SYSTEMATIC REVIEW, META-ANALYSIS, AND REAL-WORLD OBSERVATIONAL STUDY
Feb 25, 2026, 14:41 PM -
ACANTHOSIS NIGRICANS AS A CLINICAL MARKER FOR SCREENING OF POLYCYSTIC OVARY SYNDROME AMONG YOUNG WOMEN
Feb 25, 2026, 14:41 PM -
PRACTICAL APPROACHES TO BUDGET IMPACT ANALYSIS IN HTA SYSTEMS: THE ROLE OF CLINICAL EXPERTS IN UKRAINE
Feb 25, 2026, 14:41 PM -
FACTORS ASSOCIATED WITH LONGITUDINAL TRAJECTORIES OF HYDROXYUREA ADHERENCE AMONG INDIVIDUALS WITH SICKLE CELL DISEASE: A GROUP-BASED TRAJECTORY MODELING STUDY
Feb 25, 2026, 14:41 PM -
SOCIETAL IMPACT ASSESSMENT OF RIBOCICLIB FOR HR+/HER2- ADVANCED BREAST CANCER: INTEGRATING HUMAN CAPITAL AND UNPAID WORK VALUATION USING INPUT-OUTPUT ANALYSIS
Feb 25, 2026, 14:41 PM -
COMPARATIVE EFFECTIVENESS OF PHARMACOLOGICAL TREATMENTS FOR STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHINESE POPULATION: A BAYESIAN NETWORK META ANALYSIS
Feb 25, 2026, 14:41 PM -
CLINICAL BENEFIT AND ECONOMIC IMPACT OF NEWLY APPROVED ORPHAN DRUGSIN CHINA AND THE UNITED STATES: 2018-2024
Feb 25, 2026, 14:41 PM -
INDIRECT TREATMENT COMPARISON OF TEPROTUMUMAB VS RITUXIMAB OR TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Feb 25, 2026, 14:41 PM -
EXAMINING THE ASSOCIATION BETWEEN PROBLEMATIC INTERNET USE AND MENTAL HEALTH AMONG ADOLESCENTS
Feb 25, 2026, 14:41 PM -
A MULTI-INDICATION HEALTH TECHNOLOGY ASSESSMENT FRAMEWORK FOR ONCOLOGICAL DRUGS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Feb 25, 2026, 14:41 PM -
TRANSFORMING DISEASE PREVENTION THROUGH INNOVATIVE INVESTMENT MODELS: DEVELOPMENT OF A TYPOLOGY AND TOOLKIT TO SUPPORT SUSTAINABLE PREVENTION FINANCING
Feb 25, 2026, 14:41 PM -
COST PER CLINICAL WEIGHT-LOSS GOAL ACHIEVEMENT WITH SEMAGLUTIDE 2.4 MG VERSUS LIRAGLUTIDE 3 MG FROM A COLOMBIAN INSURER PERSPECTIVE
Feb 25, 2026, 14:41 PM -
DOES HEALTH EXPENDITURE BUILD TRUST? EVIDENCE FROM OECD COUNTRIES, 2010-2022
Feb 25, 2026, 14:41 PM
